Human neutrophil granulocytes die rapidly, and their survival is contingent upon rescue from programmed cell death by signals from the environment. We now show that a novel signal for delaying neutrophil apoptosis is unmethylated CpG motifs prevalent in bacterial DNA (CpG-DNA). Human neutrophils express toll-like receptor 9 that recognizes these motifs. CpG-DNA, but not mammalian DNA or methylated bacterial DNA, markedly enhanced neutrophil viability by delaying spontaneous apoptosis. Endosomal maturation of CpG-DNA is prerequisite for these actions and was coupled to concurrent activation of the extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase/Akt signaling pathways, leading to phosphorylation of BAD at Ser 112 and Ser 136 , respectively, and to prevention of decreases in mitochondrial transmembrane potential, cytochrome c release and caspase-3 activation. Consistently, pharmacological inhibition of either ERK or phosphatidylinositol 3-kinase partially reversed these actions of CpG-DNA; however, they did not produce additive inhibition. Furthermore, intravenous injection of CpG-DNA (200 µg/kg) into rats evoked slight decreases in blood pressure and induced a modest leukocytosis, whereas it effectively suppressed neutrophil apoptosis as assayed ex vivo. Our results indicate that unmethylated CpG motifs in bacterial DNA promote neutrophil survival by suppressing the apoptotic machinery and may therefore contribute to prolongation and amplification of inflammation.
influenced within the inflammatory microenvironment. Indeed, bacterial LPS and proinflammatory cytokines, such as IL-2, IL-8, and IFN-γ, can prolong the life span of neutrophils by suppressing apoptosis (2, 5, 7). Clinical studies reported markedly suppressed neutrophil apoptosis in patients with inflammatory diseases, including acute respiratory distress syndrome (8) and sepsis (9) .
Mammalian innate immune cells detect the presence of bacteria through toll-like receptors (TLR) that recognize pathogen-associated molecular patterns (10, 11) . Bacterial genomic DNA is discriminated from host-derived self-DNA and is recognized by TLR-9 (12) (13) (14) (15) (16) . Bacterial DNA contains short sequences of nonmethylated CpG dinucleotides in certain base contexts (12, 17) . CpG motifs are at least 20-fold more common in bacterial than vertebrate DNA and in eukaryotic DNA these motifs are suppressed and mostly methylated (12) . Although numerous studies have investigated the impact of bacterial DNA (CpG-DNA) on human and murine lymphocytes, macrophages and dendritic cells (reviewed in Ref. 12) , surprisingly little is known about its effects on neutrophils. Administration of CpG-DNA to mice results in neutrophil accumulation at the primary sites of infection (18, 19) . Consistent with enhanced neutrophil trafficking, CpG-DNA induces IL-8 release, triggers L-selectin shedding and up-regulation of CD11b on the surface of isolated neutrophils (20, 21); it also enhances phagocyte activity and primes for superoxide production (19, 20) . Recent studies showed that human neutrophils express TLR-9 mRNA (18, 19) and protein (18), though the TLR-9 dependence of neutrophil activation has been questioned (19).
In this study, we investigated whether CpG-DNA could delay neutrophil apoptosis. Our results demonstrate that unmethylated CpG motifs in bacterial DNA prolong the life span of neutrophils by suppressing the constitutively expressed apoptotic machinery both in vitro and ex vivo. We also found that endosomal maturation is required for CpG initiation of intracellular signaling, consistent with involvement of TLR-9. Furthermore, we also investigated the molecular mechanisms underlying the apoptosis-delaying action of CpG-DNA, observing a role for the mitogen-activated protein kinase (MAPK) kinase/extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase (PI 3kinase)/Akt signaling pathways, leading to prevention of mitochondrial dysfunction and activation of caspase-3.
MATERIALS AND METHODS

Bacterial and mammalian DNA
E. coli DNA (strain B) and calf thymus DNA (Sigma-Aldrich, St. Louis, MO) were purified by extraction with phenol:chloroform:isoamyl alcohol (25:24:1 vol/vol/vol) and ethanol precipitation. Heat-denaturated (single-stranded) genomic DNA was used in all experiments. For some experiments, E. coli DNA was treated for 16 h at 37°C with CpG methylase SssI (2 U/µg DNA) in NE Buffer 2 supplemented with 160 µM S-adenosylmethionine (New England Biolabs, Beverly, MA). Methylated DNA was purified as above. E. coli and calf thymus DNA preparations contained <5 ng LPS per mg DNA by Limulus assay.
Isolation and culture of neutrophils
Neutrophils were isolated from venous blood of healthy volunteers (male and female, 23-54 years) who had not taken any drugs for at least 14 days before the experiments (22). The Clinical Research Committee of the Maisonneuve-Rosemont Hospital approved the protocol. Neutrophils (5×10 6 cells/ml, purity >96%, viability >98%) were resuspended in Hanks' balanced salt solution (HBSS) supplemented with 10% autologous plasma and were incubated with CpG DNA, calf thymus DNA, methylated bacterial DNA, or LPS (E. coli O114:B4, 1 µg/ml) in 0.5 ml conical polypropylene tubes on a rotator (Adams Nutator, Sparks, MD) at 37°C in 5% CO 2 . In additional experiments, neutrophils were preincubated with 30 nM bafilomycin, 5 µg/ml chloroquine, 10 µM monensin, 50 µM PD98059, 100 nM wortmannin, 1 µM SB 203580, 20 µM Z-VAD-FMK, or Z-FA-FMK, 20 min before addition of CpG-DNA. At the indicated times, cells were washed once in HBSS before use in the assays described below.
Assessment of cell viability and apoptosis
Standard cytospin preparations were stained with Wright-Giemsa dye for photographic demonstration of apoptotic morphologic features. Neutrophil apoptosis was quantitated as the percent of cells with hypodiploid DNA (23) and positive annexin V staining (24). For DNA detection, neutrophils (~10 6 ) were suspended in 0.5 ml hypotonic fluorochrome solution (50 µg/ml propidium iodide in 0.1% sodium citrate plus 0.1% Triton X-100) immediately before analysis. Propidium iodide fluorescence of 10,000 individual nuclei per sample was acquired and analyzed with a FACScan flow cytometer (Becton Dickinson, San Jose, CA). For specific annexin V binding, neutrophils (10 6 ) were incubated in 100 µl binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl 2 , pH 7.4) containing a saturating concentration of R-PE-labeled annexin V for 15 min at 20°C and then washed with phosphate buffered saline before analysis by flow cytometry. Nonspecific binding was determined by using calcium-free binding buffer (10 mM HEPES, 140 mM NaCl, 10 mM EDTA, pH 7.4).
DNA fragmentation
DNA cleavage was shown by gel electrophoresis as described (25). In brief, DNA was extracted from neutrophils, precipitated, and resuspended in Tris-EDTA buffer containing 25 µg/ml RNase A (Roche, Basel, Switzerland), incubated for 5 min at 65°C, and then subjected to electrophoresis in 0.8% agarose at 80 V for 70 min. After staining with ethidium bromide, DNA was visualized by UV examination for image analysis.
Caspase-3 activity assay
Cell lysates, prepared from 10 7 neutrophils, were incubated for 60 min at 37°C in 200 µl assay buffer containing 28 µM N-acetyl-Asp-Glu-Val-Asp-AMC (BD Biosciences, Palo Alto, CA). Release of AMC from Ac-DEVD-AMC was measured using a CytoFluor microplate reader (PE Biosystems, Framingham, MA) with excitation and emission wavelengths of 340 and 460 nm, respectively.
Analysis of mitochondrial transmembrane potential (∆Ψ m )
At the indicated times, aliquots of neutrophil suspensions (5×10 5 cells) were removed, incubated for 15 min at 37°C with 10 µg/ml JC-1 (26) using the MitoPT detection kit (Immunonochemistry Technologies, Bloomington, MN), and analyzed by flow cytometry in accordance with the manufacturer's protocol.
Mitochondrial cytochrome c release
At the indicated times, neutrophils (2×10 7 cells) were harvested, and mitochondrial and cytosolic fractions were isolated using the Mitochondrial Fractionation kit (Active Motif, Carlsbad, CA). Cytochrome c levels in mitochondrial and cytosolic extracts (20 µg protein each) were determined by a selective ELISA (Active Motif). The intra-assay and inter-assay coefficients of variation were <10%.
Western blot analysis
Protein extracts were prepared by lysing 2 × 10 6 neutrophils in 100 µl lysis buffer (20 mM Tris, 1 mM EGTA, 2 mM Na 3 VO 4 , 25 mM NaF, 0.5% (vol/vol) Triton X-100, 2 mM PMSF, 40 µg/ml aprotinin, and 10 µg/ml each of chymostatin, leupeptin, and pepstatin A), and Western blot analysis of phosphorylated ERK 1/2 and Akt was performed by using the Phospho Plus ERK 1/2 and Akt Ab kits (New England Biolabs) as described (27). To assess ERK and Akt-mediated phosphorylation of BAD, Western blot analysis was performed on lysates from 2 × 10 7 cells using anti-phospho-BAD(Ser112) Ab (Biosource International, Camarillo, CA) and antiphospho-BAD(Ser136) Abs (Upstate Biotechnology, Lake Placid, NY), respectively (27).
Preparation of high-purity neutrophil
Neutrophils (10 7 ) enriched by Ficoll centrifugation were incubated for 30 min at 4°C with 20% heat-inactivated autologous serum prepared in HBSS, washed twice, and simultaneously labeled for 30 min at 4°C with R-PE-conjugated anti-CD16, FITC-labeled anti-CD19, FITC-labeled anti-CD3, and FITC-labeled anti-HLA-DR (all from BD PharMingen, San Diego, CA) according to the manufacturer's instructions. After two washes with HBSS, cells were subjected to dual channel FACS analysis on a FACSVantage cytometer (Becton Dickinson). Neutrophils, defined as CD16
-, CD19 -, and HLA-DR -cells, were separated by sorting with a flow rate of 10,000 cells/s. Gates were set to exclude debris and non-viable cells on the basis of light-scatter properties. Aliquots of the sorted cells were reanalyzed on a FACScan flow cytometer and were routinely >99.9% pure and >92% viable (determined by trypan blue exclusion).
TLR-9 expression
Freshly isolated neutrophils or neutrophils were incubated for 2 h at 37°C with CpG-DNA (1.6 µg/ml), permeabilized with Permeabilization Buffer (eBioscience, San Diego, CA), and stained with a R-PE-conjugated anti-human TLR-9 Ab eB72-1665 or a class-matched irrelevant Ab (eBioscience). Neutrophil TLR-9 expression was assessed on a FACScan flow cytometer. In additional experiments, high-purity (>99.9%) neutrophils were lysed as described above, and TLR-9 was detected by Western blotting using a mouse anti-human TLR-9 Ab (eBioscience).
Animal experiments
The experiments were performed on conscious chronically catheterized male Wistar rats (Crl:(Wi)BR, Charles River, St-Constant, QC, Canada) weighing 300 to 350 g. The Hospital's Animal Care Committee approved the procedures. The animals were housed in individual metabolic cages, and catheters were implanted into the abdominal aorta and vena cava as described previously (28). Five days were allowed to complete recovery from surgery. During the experiments, the animals could move freely and have free access to water. Mean arterial blood pressure and heart rate was monitored continuously by a blood pressure analyzer (MicroMed, Louisville, KY) with a COBE CDX III pressure transducer. Following baseline hemodynamic measurements, the animals were given a bolus intravenous injection of CpG-DNA (200 µg/kg body weight in 100 µl; n=5), calf thymus DNA (n=4), or their vehicle (n=4). After 60 min, under isofluorane anesthesia, blood (10-13 ml) was collected by cardiac puncture into heparinized syringes and then processed to isolate neutrophils with centrifugation through FicollHypaque following dextran sedimentation as described above. The resulting cell preparations contained >95% neutrophils with cell viability >90%. Absolute red blood cell, white blood cell, and platelet counts were performed with a Coulter MicroDiff II automated hematology analyzer. White blood cell differential counts were performed on samples stained with Wright's stain. The percentage of viable and apoptotic neutrophils was assessed by flow cytometry following staining with FITC-conjugated annexin V (BD PharMingen) and propidium iodide (5 µg/ml) immediately upon completing cell isolation and after 2 and 22 h incubation of neutrophil suspensions at 37°C.
Statistical analysis
Results are expressed as means ± SEM. Statistical comparisons were made by ANOVA using ranks (Kruskal-Wallis test) followed by Dunn's multiple contrast hypothesis test to identify differences between various treatments or by Mann-Whitney U-test. P values <0.05 were considered significant for all tests.
RESULTS
TLR-9 expression in neutrophils
Western blot analysis of lysates of high purity (>99.9%) human neutrophils revealed the presence of TLR-9 in neutrophils (Fig. 1A) . Human peripheral blood mononuclear cells served as a positive control (16), whereas Jurkat J77 T cells (16) and red blood cells served as negative controls (Fig. 1) . The presence of TLR-9 in neutrophils was further confirmed by flow cytometry using an R-PE-tagged TLR-9 antibody (Fig. 1B) . In this assay neutrophils were first permeabilized, for TLR-9 is expressed in intracellular vesicles (29) . Culture of neutrophils with CpG-DNA for 2 h resulted in a modest increase in TLR-9 staining (Fig. 1B) .
CpG-DNA, but not mammalian DNA, prolongs neutrophil survival by delaying apoptosis
As expected, control (untreated) isolated neutrophils developed prominent features of apoptosis, including loss of membrane asymmetry (assessed by annexin V binding), diminution in cell volume, chromatin condensation, and internucleosomal cleavage of DNA, resulting in hypodiploid nuclei, within 24 h of culture. CpG-DNA effectively suppressed the development of apoptotic morphology and increased the percentage of viable neutrophils at each of the time points studied ( Fig. 2A-C) . The apoptosis inhibitory action was concentration-dependent with an EC 50 value of 170-320 ng/ml (Fig. 2C) . The apparent maximum inhibition that can be achieved with CpG-DNA was similar to that seen with 1 µg/ml LPS ( Fig. 2A, D) . Although considerable proportions of CpG-DNA-treated neutrophils retained a non-apoptotic morphologic appearance after 24 to 48 h in culture, cell viability decreased below 18%, and more than 81% of cells stained positive for annexin V by 72 h. Neither calf thymus DNA nor methylated E. coli DNA affected significantly the percentage of viable cells and annexin V binding (Fig. 2D) . Likewise, LPS at 0.03 ng/ml (the maximum level of contamination detected in our DNA preparations) was without detectable effects (data not shown). Electrophoretic analysis demonstrated the ability of CpG-DNA to inhibit DNA fragmentation, considered to be a hallmark of apoptosis (Fig. 2E ). The effects of 1.6 µg/ml CpG-DNA were comparable with those of 1 µg/ml LPS (Fig. 2E ).
Endosomal acidification inhibitors block the anti-apoptotic action of CpG-DNA
To test whether endosomal acidification of CpG-DNA is a necessary step for initiating intracellular signaling, neutrophils were cultured in the absence or presence of specific inhibitors previously shown to block endosomal acidification of CpG-DNA, including bafilomycin A, chloroquine, and monensin, which have different mechanisms of action (30) (31) (32) . Although these inhibitors by themselves slightly decreased neutrophil viability, they almost completely reversed the apoptosis-suppressing action of CpG-DNA (Fig. 3A) , indicating the involvement of a pHdependent step in CpG-DNA signaling. In contrast, these inhibitors had no detectable effects on LPS suppression of neutrophil apoptosis (Fig. 3B ).
CpG-DNA induces phosphorylation of BAD via the MAPK kinase/ERK and PI 3-kinase/Akt signaling pathways
To assess the downstream intracellular signaling pathways that mediate the apoptosis-delaying action of CpG-DNA, we studied the activation of several MAP kinases known to regulate neutrophil survival. CpG-DNA induced a transient, time-and concentration-dependent phosphorylation of ERK 1/2 and Akt relative to unstimulated controls (Fig. 4A, B) . Phosphorylation of both ERK 1/2 and Akt was rapid in onset, reaching a peak within 15 min. The relative degree of ERK 1/2 and Akt phosphorylation induced by LPS (1 µg/ml) is shown for comparison (Fig. 4A) .
To confirm the role of Akt and ERK activation in mediating the apoptosis-delaying action of CpG-DNA, we used selective pharmacological inhibitors. Neither the MAPK/ERK kinase inhibitor PD98059, nor the PI 3-kinase (the up-stream regulator of Akt activation) inhibitor wortmannin alone, affected development of neutrophil apoptosis, whereas the p38 MAPK inhibitor SB203580 significantly increased the percentage of viable cells and reduced the percentage of annexin V positive cells and neutrophils exhibiting hypodiploid nuclei (P<0.01 compared with untreated control; Fig. 4B ). Both PD98059 and wortmannin effectively blocked the apoptosis-delaying action of CpG-DNA, albeit complete inhibition was never observed. The effects of PD98059 and wortmannin were not additive (Fig. 4B) . Similar results were obtained when another PI 3-kinase inhibitor, LY294002 was used instead of wortmannin (data not shown). Co-treatment of neutrophils with CpG-DNA and SB203580 resulted in a similar degree of suppression of neutrophil apoptotic features than those observed with either CpG-DNA or SB203580 alone (Fig. 4B) . Pretreatment of neutrophils with PD98059 inhibited CpG-DNAinduced phosphorylation of ERK 1/2 without affecting Akt phosphorylation, and pretreatment with wortmannin inhibited Akt phosphorylation but did not block ERK 1/2 phosphorylation (Fig.  4C) .
Next, we studied phosphorylation of BAD, a downstream target for both ERK and Akt. CpG-DNA induced concentration-dependent phosphorylation of BAD at both Ser112 and Ser136 relative to unstimulated control neutrophils (Fig. 4D) . PD98059 inhibited CpG-DNA-induced phosphorylation at Ser112, but not at Ser136; wortmannin blocked phosphorylation at Ser136 without affecting phosphorylation at Ser112 (Fig. 4E) .
CpG-DNA inhibits disruption of mitochondrial transmembrane potential, cytochrome c release and activation of caspase-3
The ∆Ψ m was measured at different time points using the fluorochrome JC-1 and FACS analysis (26). Significant reduction in ∆Ψ m was detected in neutrophils undergoing spontaneous apoptosis at 4 h of culture. Culture of neutrophils for 8 and 22 h was associated with further decreases in ∆Ψ m (Fig. 5A, B) . Disruption of ∆Ψ m was partially inhibited in the presence of CpG-DNA (Fig.  5B ), but not in the presence of calf thymus DNA (data not shown). The inhibitory action of CpG-DNA was concentration-dependent (Fig. 5C) , and the apparent maximum inhibition that could be achieved with CpG-DNA was comparable to that of 1 µg/ml LPS (Fig. 5A ).
To link changes in ∆Ψ m to cytochrome c release, we measured cytochrome c levels in the mitochondrial and cytosolic fractions with a selective ELISA. As expected, cytochrome c was predominantly localized in the mitochondria in freshly isolated neutrophils (Fig. 5D) . Culture of neutrophils for 24 h resulted in release of cytochrome c into the cytosol that was markedly attenuated in the presence of CpG-DNA (Fig. 5D) . The CpG-DNA inhibition of mitochondrial cytochrome c liberation was comparable with that observed with 1 µg/ml LPS (Fig. 5D ).
Caspase-3 activity was barely detectable in freshly isolated neutrophils. In vitro culture of neutrophils for 24 h resulted in marked increases in caspase-3 activity that were reduced by CpG-DNA in a concentration-dependent fashion with an EC 50 value of 380 ng/ml (Fig. 5E ). Both PD98059 and wortmannin attenuated the caspase-3 inhibitory action of CpG-DNA, although complete reversal was not achieved, not even with the co-administration of PD98059 and wortmannin (Fig. 5F ).
Pretreatment of neutrophils with the pan-caspase inhibitor Z-VAD-FMK effectively suppressed the development of apoptosis, resulting in significant increases in the number of viable cells as assessed after 24 h of culture (Fig. 6) . Although co-treatment with Z-VAD-FMK and CpG-DNA resulted in slightly higher increases in the number of viable cells, and slightly greater suppression of the percentage of apoptotic cells than CpG-DNA alone, these changes did not reach statistical significance (Fig. 6 ). Z-VAD-FMK and LPS alone suppressed neutrophil apoptosis to a similar degree, and their inhibitory actions were not addictive (Fig. 6) . Neither Z-FA-FMK (a negative control) nor 0.1% dimethyl sulfoxide (the vehicle of Z-VAD-FMK) produced any detectable effects (Fig. 6 ).
CpG-DNA inhibits neutrophil apoptosis in rats
To investigate whether the neutrophil apoptosis-delaying action of CpG-DNA can be observed in vivo, we injected CpG-DNA into conscious rats. Since neutrophils are removed from the circulation upon expression of phosphatidylserine on their surface (an early sign of apoptosis; 1, 5), we collected blood by cardiac puncture 60 min after administration of CpG-DNA and assessed neutrophil viability and apoptosis ex vivo immediately upon completing neutrophil isolation, and following 2 and 20 h culture of isolated neutrophils.
Intravenous administration of CpG-DNA into rats resulted in transient 15 to 29 mmHg decreases in mean arterial blood pressure, which were associated with suppression of heart rate (Fig. 7A) . Neither mean arterial blood pressure nor heart rate returned to preinjection values within 60 min after CpG-DNA injection. CpG-DNA evoked a slight leukocytosis by increasing the number of circulating neutrophils, but not monocytes and lymphocytes (Fig. 7B) . Red blood cell and platelet counts were not affected (Fig. 7B) . Injection of calf thymus DNA or vehicle did not evoke any detectable changes in the parameters studied (Fig. 7) .
Flow cytometry analysis performed immediately after completing neutrophil isolation revealed slightly higher number of viable neutrophils and a slightly lower percentage of annexin V positive cells in neutrophils isolated from animals that were treated with CpG-DNA than in neutrophils prepared from rats who received either calf thymus DNA or vehicle (Fig. 8) . Ex vivo culture of isolated neutrophils from vehicle or calf thymus DNA-treated rats resulted in similar time-dependent reductions in cell viability with concomitant increases in the percentage of annexin V positive cells (Fig. 8) . By contrast, while cell viability also decreased and the percentage of annexin V positive cells increased with time in neutrophils from CpG-DNAtreated animals, considerably fewer neutrophils showed signs of apoptosis in this group even after 20 h culture than in the vehicle-or calf thymus DNA-treated group (Fig. 8) .
DISCUSSION
Progression to apoptosis appears to be the normal default state for circulating neutrophils, whereas prolonged neutrophils survival is required for excessive leukocyte trafficking into injured tissues and amplification of the inflammatory response. Neutrophil survival is contingent upon rescue from programmed cell death by signals from the environment. Here we describe that a novel signal for delaying neutrophil apoptosis is bacterial DNA, and unmethylated CpG motifs in particular.
Consistent with the commitment of neutrophils to apoptosis, CpG-DNA delayed, rather than blocked, apoptosis and resulted in prolonged neutrophil survival as assessed both in vitro and ex vivo. Our results indicate that unmethylated CpG motifs are responsible for induction of these actions, since methylation of cytosines in CpG dinucleotides in bacterial DNA completely abolished its apoptosis suppressing activity, and that calf thymus DNA did not reproduce the effects of bacterial DNA. CpG dinucleotides are suppressed in mammalian DNA and are commonly methylated (33) . These observations suggest that differences in methylation patterns would enable neutrophils to selectively recognize bacterial DNA, although we cannot exclude a role for inhibitory sequences in mammalian DNA that can mask stimulatory CpG motifs (34, 35) . Furthermore, the CpG-DNA effects were not due to endotoxin contamination, since culture of neutrophils with 0.03 ng/ml LPS (the highest level of LPS detected in our DNA preparations) did not result in detectable effects. Thus, CpG-DNA exerts an anti-apoptotic action similar to those of LPS (2, 4), glucocorticoids (36), GM-CSF (2, 7), structurally modified C-reactive protein (37) or IL-8 (7), and the degree of the CpG-DNA inhibition is comparable with that observed with LPS.
We also observed the neutrophil apoptosis-delaying action of CpG-DNA in rats. Since circulating neutrophils have a short half-life (~12 h) and are rapidly removed from the circulation upon expression of phosphatidylserine (the "eat me" signal for macrophages) on their surface (1, 5), we assessed neutrophil apoptosis ex vivo. Intravenous administration of CpG-DNA (200 µg/kg) evoked only modest transient decreases in mean arterial blood pressure, effectively repressed neutrophil apoptosis and prolonged survival. Such changes were already detectable immediately after blood collection and isolation of neutrophils and became more pronounced following in vitro culture of rat isolated neutrophils. Normal rat blood contains less neutrophils than human blood, but the number of neutrophils can rapidly increase in response to proinflammatory stimuli. The slight, but statistically significant elevations of white blood cell count detected at 60 min post-CpG-DNA was most likely due to increases in the number of neutrophils, which suggests that CpG-DNA can mobilize neutrophils from the bone marrow. It should be noted that a higher percentage of freshly isolated rat neutrophils than human neutrophils stained positive for annexin V. Although we do not know whether these reflect species differences or differences in the blood collection procedure, our study documents the anti-apoptotic action of CpG-DNA both in human neutrophils in vitro and rat neutrophils ex vivo regardless of the differences in the baseline levels of annexin V positive (apoptotic) cells. Our in vitro data point to a direct effect of CpG-DNA on neutrophils, although we cannot exclude the possibility that other mechanism(s), e.g., release of cytokines from other cells, might have contributed to its anti-apoptotic action in vivo.
Previous studies suggested a requirement for an intracellular pH-dependent step for CpG-DNAmediated activation of murine monocytes and B lymphoma cells (38) . Our results indicate that suppression of human neutrophil apoptosis by CpG-DNA also involves this pathway. Indeed, pretreatment of human neutrophils with bafilomycin A, which inhibits vacuolar H + -ATPase (31), chloroquine, or the ionophore antibiotic monensin, which accumulate in and increase the pH in endosomes (30, 32, 38, 39) , rendered the apoptotic machinery unresponsive to CpG-DNA but not to LPS. Endosomal acidification of CpG-DNA is thought to be a critical step to initiate intracellular signaling through binding to TLR-9 (15, 16) or the catalytic subunit of the DNAdependent protein kinase (13, 40) . Human neutrophils lack DNA-dependent protein kinase (41), but they do express TLR-9 mRNA (20, 21) and stain positive with an anti-TLR-9 antibody (20). Our flow cytometry and Western blot analysis of high-purity (>99.9%) neutrophils confirm the presence of TLR-9. Consistent with the weak expression of TLR-9 mRNA in CD4 + or CD8 + T cells that are generally considered to be negative controls (16), we detected a faint signal for TLR-9 in Jurkat T cells. We also observed an increase in TLR-9 staining following CpG-DNA treatment. The mechanism(s) by which CpG-DNA up-regulated expression of its own receptor as well as the functional importance of increased TLR-9 expression remain to be investigated.
Interestingly, this action of CpG-DNA resembles to that of GM-CSF (20).
A recent study suggested a TLR-9-independent mechanism for bacterial DNA-induced neutrophil activation (assessed by L-selectin shedding, CD11b up-regulation and IL-8 secretion; 21). However, this suggestion was, in part, based on the observation that wortmannin, which was described by these investigators as an inhibitor of TLR-9 signaling, failed to affect neutrophil activation by CpG-DNA. This is not surprising, since numerous studies have documented that these neutrophil responses are not mediated via the PI 3-kinase signaling pathway (27, 37, 42, 43) . Moreover, studies on murine macrophages, dendritic cells and human epithelial cells demonstrated CpG-DNA-induced activation of a wide spectrum of kinases, including NF-κB-inducing kinase, jun-N-terminal kinase, ERK and p38 MAPK (13, 39, 44) .
Intracellular acidification is also related to activation of DNA degradation, and bafilomycin A rendered neutrophils insensitive to the anti-apoptotic action of G-CSF (45). Although we cannot exclude the possibility that this mechanism might have contributed to the bafilomycin reversal of the apoptosis-delaying action of CpG-DNA, one should note that CpG-DNA can suppress apoptosis to a much greater degree than G-CSF, indicating involvement of additional mechanisms. Interestingly, endosomal acidification inhibitors did not affect the anti-apoptotic action of LPS. Maintaining intracellular pH above 7.2 did not prevent apoptosis in a cytotoxic T cell line (46) . Taken together, these observations would suggest that an intracellular acid pH is not essential for apoptosis. Indeed, apoptotic cells appear to retain a functional Na Suppression of neutrophil apoptosis by IL-8 (7), GM-CSF (2), or monomeric C-reactive protein (37) is predominantly mediated through concurrent activation of the ERK and Akt signaling pathways. Transient activation of PI 3-kinase without ERK activation may not be sufficient to delay apoptosis (7) . The present study provides two lines of evidence that CpG DNA also utilizes these pathways: (i) culture of neutrophils with CpG-DNA resulted in a rapid phosphorylation of both ERK 1/2 and Akt (the target of PI 3-kinase), and (ii) inhibition of MAPK/ERK kinase with PD98059 or inhibition of PI 3-kinase with wortmannin or LY294002 markedly attenuated, although never fully reversed, the apoptosis-delaying action of CpG-DNA. However, the combination of PD98059 with wortmannin or LY294002 did not produce an additive inhibition, indicating that ERK 1/2 and Akt work in concert to delay neutrophil apoptosis. Evidence indicates that neither ERK nor Akt interfere with p38 MAPK signaling. Spontaneous neutrophils apoptosis is associated with phosphorylation of p38 MAPK (37, 47) and subsequent activation of caspase-3. Conversely, the specific p38 MAPK inhibitor SB203580 partially rescued neutrophils from apoptosis (37, 47) . Transient inactivation of p38 MAPK has been suggested to contribute to the early phase of Fas-induced neutrophil apoptosis (48) . However, it is unlikely that p38 MAPK represents a survival signal under our experimental conditions, because SB203580 by itself suppressed apoptosis and the apoptosis delaying actions of SB203580 and CpG-DNA were not additive.
Our results indicate that the MAPKK/ERK and PI 3-kinase/Akt pathways converge on BAD, a member of the Bcl-2 family. Both Akt and ERK can phosphorylate BAD (49, 50) . We observed CpG-DNA-induced phosphorylation of BAD at Ser112 and Ser136 through activation of ERK and Akt, respectively. The findings that PD98059 did not block Akt-dependent BAD phosphorylation, whereas wortmannin failed to affect ERK-dependent BAD phosphorylation would argue against a cross communication between these two pathways. Phosphorylated BAD then dissociates from Bcl-2, thereby enhancing the anti-apoptotic effects of the Bcl-2 family proteins. Among other actions, these proteins could prevent mitochondrial membrane potential transition, and consequently loss in ∆Ψ m that occurs in cells irreversibly committed to programmed cell death (51) (52) (53) . Recent evidence indicates that mature neutrophils do contain an unexpectedly large number of mitochondria (54) . In this study, we succeeded to demonstrate that CpG-DNA can partially prevent decreases in ∆Ψ m and subsequent cytochrome c release occurring during spontaneous neutrophil apoptosis. Moreover, the degree of CpG-DNA reduction of neutrophil apoptosis and inhibition of mitochondrial membrane perturbation was similar. Preservation of ∆Ψ m and attenuation of cytochrome c release by CpG-DNA are consistent with decreased caspase-3 activation as detected in this study. The results from the experiments using the pan-caspase inhibitor Z-VAD-FMK and CpG-DNA confirm the importance of CpG-DNA inhibition of caspase-3 activation. These observations indicate that a major mechanism by which CpG-DNA inhibits the neutrophil intrinsic pro-apoptotic machinery is ERK and PI 3-kinase-dependent prevention of mitochondrial dysfunction and repression of caspase-3 activity (Fig. 9 ).
The present findings could have a profound impact on the way we think about neutrophil survival required for excessive leukocyte recruitment into inflamed tissues. If bacterial DNA is proinflammatory as indicated by the present and previous studies (18, 55), then simply killing bacteria may not be sufficient to counter inflammation. Indeed, DNA from dead bacteria would be still present and could, among other actions, activate neutrophils, promote leukocyte trafficking, and suppress spontaneous neutrophil apoptosis, leading to induction and/or maintaining an inflammatory response. Intriguingly, up to 1% of DNA extracted from the sputum of cystic fibrosis patients is of bacterial origin, and injection of the total DNA isolates to mice evoked inflammatory responses similar to those seen with E. coli DNA (18). Furthermore, CpG-DNA may act in synergy with LPS, for example, to induce secretion of interferon-γ (56) or NO (57) , and to enhance the toxicity of LPS (56).
In summary, our results demonstrate that unmethylated CpG motifs in bacterial DNA promote neutrophil survival by suppressing the apoptotic machinery. This action is mediated, in part, through concurrent stimulation of the MAPKK/ERK and PI 3-kinase/Akt signaling pathways, leading to prevention of mitochondrial dysfunction and inhibition of caspase-3 activation. The neutrophil apoptosis-delaying action of CpG-DNA can be observed both in vitro and ex vivo, and may therefore contribute to prolongation and amplification of the inflammatory response. suspension culture. Cytospin preparations of neutrophils were stained immediately after isolation of neutrophils (0 h) or after culture for 24 h in the absence (untreated) or presence of CpG-DNA, calf thymus DNA (both at 1.6 µg/ml), or LPS (1 µg/ml; B-C) kinetic analysis and concentration dependence of the effects of CpG-DNA on neutrophil viability and development of apoptotic morphology. Aliquots of neutrophils were stained with propidium iodide (to assess viability) or with annexin V or were processed for nuclear DNA content analysis. D) Neutrophils were cultured for 24 h at 37°C in the absence (untreated) or presence of CpG, calf thymus, or methylated bacterial DNA (met-CpG-DNA) (all at 1.6 µg/ml) or LPS (1 µg/ml), then stained with propidium iodide or annexin V. Results are the mean ± SE for five to eight experiments using neutrophils from different blood donors. *P < 0.05; **P < 0.01; ***P < 0.001 (compared with untreated). E) CpG-DNA attenuates chromatin cleavage in neutrophils maintained in culture for 24 h. Lane 1, DNA kilobase marker standards, and values for selected standards are shown on the left margin; lane 2, unstimulated (control); lane 3, CpG-DNA, 400 ng/ml; lane 4, CpG-DNA, 800 ng/ml; lane 5, CpG-DNA, 1.6 µg/ml; lane 6, LPS, 1 µ g/ml). The experiments were repeated three times. , chloroquine (5 µg/ml), or monensin (10 µM) and then cultured for 24 h at 37°C with or without CpG-DNA (1.6 µg/ml) (A) or LPS (1 µg/ml) (B). C, control (untreated). Aliquots of neutrophils were stained with propidium iodide (to assess viability) or with annexin V or were processed for nuclear DNA content analysis. Results are the mean ± SE for six experiments using neutrophils from different donors. *P < 0.05; **P < 0.01 (vs untreated). Fig. 4 (cont) µM) with or without CpG-DNA (1.6 µg/ml). Aliquots of neutrophils were stained with propidium iodide (to assess viability) or with annexin V or were processed for nuclear DNA content analysis. Results are the mean ± SE for six experiments using neutrophils from different donors. *P < 0.05; **P < 0.01 (vs untreated); ##P < 0.01 (compared with CpG-DNA-treated). C) Inhibition of CpG-DNA-induced ERK and Akt phosphorylation by PD98059 or wortmannin, respectively. The experiments were repeated four times. D-E) CpG-DNA-induced phosphorylation of BAD. Neutrophils were challenged with various concentrations of CpG-DNA for 20 min (D) or were preincubated with PD98059, wortmannin, or SB203580 for 15 min, and then challenged with CpG-DNA (1.6 µg/ml) for 15 min (E). Proteins were then isolated and probed sequentially with phospho-specific antibodies and their appropriate control. C, control (untreated). The experiments were repeated four times. were incubated with or without CpG-DNA for the indicated times, then aliquots of 10 5 cells were incubated for 15 min with JC-1 (10 µg/ml) and analyzed by cytoflourometry. A) Representative plots. The percentages on representative plots reflect the reduction in ∆Ψ m , 0 h refers to staining immediately after isolation of neutrophils. The effect of LPS (1 µg/ml) is shown for comparison. B) Time-dependency of the effect of CpG-DNA (1.6 µg/ml) on ∆Ψ m . C) Concentrationdependent effects of CpG-DNA on ∆Ψ m assessed after 8-h incubation. The results are the mean ± SE of six experiments. D) Mitochondrial and cytosolic cytochrome c levels in freshly isolated (0 h) neutrophils and in neutrophils cultured for 24 h in the absence or presence of CpG-DNA (1.6 µg/ml) or LPS (1 µg/ml). The results are the mean ± SE of four to seven experiments. *P < 0.05; **P < 0.01. E) Concentration-dependent inhibition of caspase-3 activity. Caspase-3 activity was determined by using Ac-DEVD-AMC as a substrate and was expressed as fluorescence units (FU) . No fluorescence was detected in the presence of Ac-DEVD-aldehyde, an inhibitor of caspase-3 activity. F) Reversal of the CpG-DNA effect on caspase-3 activity by PD98059 (50 µM) and wortmannin (100 nM). Values are the mean ± SE of five independent experiments. *P < 0.05; **P < 0.01 (vs untreated); #P < 0.05 (vs CpG DNA-treated). , or their vehicle dimethyl sulfoxide (DMSO, 0.1%) and were then cultured for 24 h at 37°C with or without CpG-DNA (1.6 µg/ml) or LPS (1 µg/ml). Aliquots of neutrophils were stained with propidium iodide (to assess viability) or with annexin V or were processed for nuclear DNA content analysis. Results are the mean ± SE for six experiments using neutrophils from different donors. *P < 0.05; **P < 0.01 (vs untreated). thymus DNA (200 µg/kg) or their vehicle was injected intravenously at 0 min (arrow). A) Effects on mean arterial blood pressure and heart rate. B) Effects on blood cells. At 60 min post-DNA injection, under light anesthesia, blood was collected via cardiac puncture, and blood cell counts and leukocyte differential counts were determined. Values are the mean ± SE of four to five animals per group. *P < 0.05; **P < 0.01 (vs vehicle). 
